Performance Insights and Support for a Smooth Transition
We are excited to introduce our second-generation iLite® cells, designed to optimize your bioassay workflows and enhance data reliability. This blog post provides an in-depth look at the performance studies conducted on these new cell lines compared to the first-generation cells.
The second-generation iLite cells provide several advantages:
- A significant reduction in assay time, decreasing from 18 hours to just 5 hours while maintaining the integrity of the results.
- Improved accuracy and consistency of data through the incorporation of Renilla normalization.
- An assay-ready format that eliminates the need for labor-intensive cell culture procedures, streamlining the workflow and reducing resource costs.
iLite® Type I IFN FAST